Montreal, Canada-based Valeant Pharmaceuticals will acquire Hayward, Calif.-based Solta Medical at a total transaction value of about $250 million, according to a NASDAQ report.
Valeant Pharmaceuticals agreed to purchase Solta Medical's shares at $2.92 per cash share. The deal is expected to close in the first quarter of 2014.
Solta Medical develops energy-based aesthetic medical device systems. Its total revenue in 2012 was $145 million, according to the report.
More Articles on Supply Chain Transactions:
CVS, Cardinal Health Enter Generic Drug Joint Venture
Northeast Purchasing Coalition Moves to Online Contracting
Myco Medical, Novation Enter Private-Label Contract